MCID: IRR001
MIFTS: 27

Irregular Astigmatism malady

Category: Eye diseases

Aliases & Classifications for Irregular Astigmatism

About this section

Aliases & Descriptions for Irregular Astigmatism:

Name: Irregular Astigmatism 11 13 67

Classifications:



External Ids:

Disease Ontology11 DOID:13919
ICD1029 H52.21
SNOMED-CT61 47099006
ICD9CM31 367.22

Summaries for Irregular Astigmatism

About this section
MalaCards based summary: Irregular Astigmatism is related to keratoconus 5 and keratoconus 1. An important gene associated with Irregular Astigmatism is LOXL3 (Lysyl Oxidase Like 3). Affiliated tissues include eye and endothelial, and related mouse phenotype vision/eye.

Related Diseases for Irregular Astigmatism

About this section

Diseases related to Irregular Astigmatism via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 15)
idRelated DiseaseScoreTop Affiliating Genes
1keratoconus 510.9
2keratoconus 110.9
3astigmatism10.7
4keratoconus10.1
5cataract9.9
6endotheliitis9.9
7dilated cardiomyopathy9.9RPS27, RPS29
8keratitis9.8
9myopia9.8
10anisometropia9.8
11corneal ectasia9.8
12leber congenital amaurosis9.6PRDM5, VSX1
13cerebral artery occlusion9.5CHST6, VSX1
14retinal drusen9.3CHST6, VSX1
15bacterial esophagitis7.9CHST6, LOXL3, NYX, PRDM5, RPS27, VSX1

Graphical network of diseases related to Irregular Astigmatism:



Diseases related to irregular astigmatism

Symptoms for Irregular Astigmatism

About this section

Drugs & Therapeutics for Irregular Astigmatism

About this section

Drugs for Irregular Astigmatism (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 26)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Lidocaineapproved, vet_approvedPhase 2, Phase 31226137-58-63676
Synonyms:
.alpha.-(Diethylamino)-2,6-acetoxylidide
.alpha.-Diethylamino-2,6-dimethylacetanilide
.alpha.-Diethylaminoaceto-2,6-xylidide
.omega.-Diethylamino-2,6-dimethylacetanilide
137-58-6
2-(Diethylamino)-2',6'-acetoxylidide
2-(Diethylamino)-N-(2,6-dimethylphenyl)acetamide
2-Diethylamino-N-(2,6-dimethyl-phenyl)-acetamide
2-Diethylamino-N-(2,6-dimethylphenyl)acetamide
4-12-00-02538 (Beilstein Handbook Reference)
6108-05-0 (MONOHYDROCHLORIDE MONOHYDRATE))
6108-05-0 (mono-hydrochloride, mono-hydrate)
73-78-9 (mono-hydrochloride)
AB00053581
AC-10282
AC1L1GGQ
AC1Q2Z7J
AKOS001026768
ARONIS23855
After Burn Double Strength Gel
After Burn Double Strength Spray
After Burn Gel
After Burn Spray
Alphacaine
Anestacon
Anestacon Jelly
BIDD:GT0342
BPBio1_000197
BRD-K52662033-001-02-6
BRD-K52662033-003-05-5
BRN 2215784
BSPBio_000179
BSPBio_001359
BSPBio_003004
Bio-0767
Bio1_000379
Bio1_000868
Bio1_001357
Bio2_000079
Bio2_000559
C07073
C14H22N2O
CAS-73-78-9
CDS1_000283
CHEBI:6456
CHEMBL79
CID3676
CPD000058189
Cappicaine
Cito optadren
Cuivasil
D00358
DB00281
Dalcaine
Dentipatch
Dentipatch (TN)
DermaFlex
Diethylaminoaceto-2,6-xylidide
Dilocaine
DivK1c_000174
DivK1c_001323
Duncaine
EINECS 205-302-8
ELA-Max
EMBOLEX
Emla
Emla Cream
Esracaine
FT-0082378
Gravocain
HMS1791D21
HMS1989D21
HMS2051C21
HMS2089E15
HMS548M19
HSDB 3350
I01-2704
IDI1_000174
IDI1_033829
Isicaina
Isicaine
Jetocaine
KBio1_000174
KBio2_000079
KBio2_001598
KBio2_002647
KBio2_004166
KBio2_005215
KBio2_006734
KBio3_000157
KBio3_000158
KBio3_002224
KBioGR_000079
KBioGR_000599
KBioSS_000079
KBioSS_001598
L-Caine
L0156
L1026_SIGMA
L7757_SIGMA
LIDOCAINE (73-58-6 (MONOHYDROCHLORIDE)
LIDOPEN
LQZ
 
LS-805
Lanabiotic
Leostesin
Lida-Mantle
Lidocaina
Lidocaina [INN-Spanish]
Lidocaine (JP15/USP/INN)
Lidocaine (VAN)
Lidocaine Carbonate
Lidocaine Hydrocarbonate
Lidocaine Monohydrochloride
Lidocaine [USAN:INN:JAN]
Lidocainum
Lidocainum [INN-Latin]
Lidocaton
Lidoderm
Lidoject-1
Lidoject-2
Lignocaine
Lignocainum
Lingocaine
Lopac-L-5647
Lopac0_000669
MLS000069724
MLS000758263
MLS001074177
Maricaine
Maybridge1_002571
MolPort-001-783-478
N-(2,6-dimethylphenyl)-N(2),N(2)-diethylglycinamide
N-(2,6-dimethylphenyl)-N~2~,N~2~-diethylglycinamide
NCGC00015611-01
NCGC00015611-02
NCGC00015611-03
NCGC00015611-04
NCGC00015611-14
NCGC00022176-05
NCGC00022176-06
NCGC00022176-07
NCGC00022176-08
NCGC00022176-09
NINDS_000174
NSC 40030
NSC40030
Norwood Sunburn Spray
Octocaine
Octocaine-100
Octocaine-50
Prestwick0_000050
Prestwick1_000050
Prestwick2_000050
Prestwick3_000050
Remicaine
Rocephin Kit
Rucaina
S1357_Selleck
SAM001247018
SMR000058189
SPBio_001525
SPBio_002100
STK552033
Solarcaine
Solarcaine aloe extra burn relief cream
Solcain
Spectrum2_001343
Spectrum3_001392
Spectrum4_000070
Spectrum5_001549
Spectrum_001118
UNII-98PI200987
WLN: 2N2 & 1VMR B1 F1
Xilina
Xilocaina
Xilocaina [Italian]
Xllina
Xycaine
Xylestesin
Xylesthesin
Xylocain
Xylocaine
Xylocaine (TN)
Xylocaine 5% Spinal
Xylocaine CO2
Xylocaine Dental Ointment
Xylocaine Endotracheal
Xylocaine Test Dose
Xylocaine Viscous
Xylocaine-MPF
Xylocaine-MPF with Glucose
Xylocaine-Mpf
Xylocaine-Mpf with Glucose
Xylocard
Xylocitin
Xyloneural (free base)
Xylotox
Zilactin-L
Zingo
alfa-Dietilamino-2,6-dimetilacetanilide
alfa-Dietilamino-2,6-dimetilacetanilide [Italian]
alpha-Diethylamino-2,6-dimethylacetanilide
alpha-diethylamino-2,6-dimethylacetanilide
lidocaine
nchembio.65-comp16
α-diethylamino-2,6-dimethylacetanilide
2
DipivefrinapprovedPhase 39452365-63-63105
Synonyms:
( -)-2,2-Dimethylpropansaeure-4-(1-hydroxy-2-(methylamino)ethyl)-1,2-phenylenester
( -)-4-(1-Hydroxy-2-methylaminoethyl)-o-phenylendipivalat
(+-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol 3,4-dipivalate
(+-)-4-[1-Hydroxy-2-(methylamino)ethyl]-O-phenylene divavalate
(+-)-4-[1-hydroxy-2-(methylamino)ethyl]-o-phenylene divavalate
(RS)-4-(1-Hydroxy-2-(methylamino)ethyl)-1,2-phenylen dipivalat
1-(3',4'-Dipivaloyloxyphenyl)-2-methylamino-1-ethanol
1-(3',4'-dipivaloyloxyphenyl)-2-methylamino-1-ethanol
2,2-Dimethylpropanoic acid 4-[1-hydroxy-2-(methylamino)ethyl]-1,2-phenylene ester
4-(1-Hydroxy-2-(methylamino)ethyl)-1,2-phenylen dipivalat
4-[1-Hydroxy-2-(methylamino)ethyl]-O-phenylene divavalate
4-[1-hydroxy-2-(methylamino)ethyl]-o-phenylene divavalate
4-[1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diyl bis(2,2-dimethylpropanoate)
52365-63-6
AB00514686
AC1L1F6K
AKOS003662293
AKPro
BPBio1_000688
BRD-A47494775-003-03-0
BSPBio_000624
C06963
C19H29NO5
CHEBI:4646
CID3105
D02349
DB00449
Dipivalyl Epinephrine
 
Dipivefrin
Dipivefrin (USAN)
Dipivefrin HCL
Dipivefrin [USAN]
Dipivefrina
Dipivefrina [INN-Spanish]
Dipivefrine
Dipivefrine (INN)
Dipivefrinum
Dipivefrinum [INN-Latin]
Dipivéfrine
K 30081
L000915
LS-121419
NCGC00179499-01
Ophtho-Dipivefrin
Prestwick0_000632
Prestwick1_000632
Prestwick2_000632
Prestwick3_000632
Pro-Epinephrine
Propine
Propine C Cap B.I.D.
SPBio_002843
UNII-8Q1PVL543G
[2-(2,2-dimethylpropanoyloxy)-4-[1-hydroxy-2-(methylamino)ethyl]phenyl] 2,2-dimethylpropanoate
dipivalyl epinephrine
dipivefrin
nchembio747-comp3
3
Riboflavinapproved, nutraceutical, vet_approvedPhase 2, Phase 316583-88-5493570
Synonyms:
(-)-Riboflavin
1-Deoxy-1-(3,4-dihydro-7,8-dimethyl-2,4-dioxobenzo[g]pteridin-10(2H)-yl)-D-ribitol
1-Deoxy-1-(7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-10(2H)-yl)pentitol
6,7-Dimethyl-9-D-ribitylisoalloxazine
6,7-Dimethyl-9-ribitylisoalloxazine
7,8-Dimethyl-10-(D-ribo-2,3,4,5-tetrahydroxypentyl)-Benzo[g]pteridine-2,4(3H,10H)-dione
7,8-Dimethyl-10-(D-ribo-2,3,4,5-tetrahydroxypentyl)isoalloxazine
7,8-Dimethyl-10-ribitylisoalloxazine
Beflavin
Beflavine
Benzo[g]pteridine riboflavin deriv.
E 101
E101
Flavaxin
Flavin BB
Flaxain
Food Yellow 15
 
Hyre
Lactobene
Lactoflavin
Lactoflavine
Ribipca
Ribocrisina
Riboderm
Riboflavina
Riboflavine
Riboflavinum
Ribosyn
Ribotone
Ribovel
Russupteridine yellow III
San Yellow B
Vitaflavine
Vitamin B2
Vitamin G
Vitasan B2
4
Folic Acidapproved, nutraceutical, vet_approvedPhase 2, Phase 3427959-30-36037
Synonyms:
(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
01769_FLUKA
2d0k
33609-88-0
36653-55-1 (mono-potassium salt)
59-30-3
6484-89-5 (mono-hydrochloride salt)
AC-11682
AC1L1LNX
AI3-26387
AKOS000503224
ARONIS014410
Acfol (Spain)
Acide folique
Acide folique [INN-French]
Acido folico
Acido folico [INN-Spanish]
Acidum folicum
Acidum folicum [INN-Latin]
Acifolic
Antianemia factor
Apo-Folic
BIDD:ER0563
BIDD:GT0641
BIF0608
BPBio1_000654
BSPBio_000594
BSPBio_002338
C00504
C20H20N6O6
CAS-59-30-3
CCRIS 666
CHEBI:27470
CHEMBL1622
CID6037
CPD000471860
Cytofol
D00070
DB00158
DivK1c_000494
Dosfolat B activ
EINECS 200-419-0
F0043
F7876_SIAL
F7876_SIGMA
F8758_SIGMA
F8798_SIAL
F8890_SIGMA
FOL
Facid
Factor U
Folacid
Folacin
Folaemin
Folaemin [Netherlands]
Folan
Folasic (Australia)
Folate
Folbal
Folcidin
Folcidin (VAN)
Folcysteine
Foldine
Foldine [France]
Folettes
Foliamin
Folic
Folic acid
Folic acid (JP15/USP/INN)
Folic acid (TN)
Folic acid [BAN:INN:JAN]
Folic acid [INN:BAN:JAN]
Folic acid dihydrate
Folicet
Folicet (TN)
Folico
Folico (Italy)
Folina
Folina (Italy)
Folipac
Folsaeure
 
Folsan
Folsaure
Folsav
Folvite
Folvron
Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L
HMS1921D20
HMS2092N17
HMS501I16
HSDB 2002
IDI1_000494
InChI=1/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s
Incafolic
KBio1_000494
KBio2_001861
KBio2_004429
KBio2_006997
KBio3_001558
KBioGR_002222
KBioSS_001861
Kyselina listova
Kyselina listova [Czech]
LS-2157
Liver Lactobacillus casei factor
MLS001304016
MLS001335861
Millafol
Mission prenatal
Mittafol
MolPort-004-285-551
N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo- yl)-L-glutamic acid
N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-(4-{[(2-Amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-Pteroyl-L-glutamic acid
N-[(4-{[(2-Amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[4-[[(2-Amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-L-glutamic acid
NCGC00016265-01
NCGC00142391-01
NINDS_000494
NSC 3073
Nifolin
Nifolin [Denmark]
Novofolacid
Novofolacid [Canada]
PGA
PGA (VAN)
Prestwick3_000627
Prestwick_230
PteGlu
Pteroyl-L-glutamate
Pteroyl-L-glutamic acid
Pteroyl-L-monoglutamate
Pteroyl-L-monoglutamic acid
Pteroylglutamate
Pteroylglutamic acid
Pteroylmonoglutamate
Pteroylmonoglutamic acid
SAM002264616
SDCCGMLS-0066738.P001
SMP2_000137
SMR000471860
SPBio_001357
SPECTRUM1502020
Serum Folate Level
Spectrum2_001459
Spectrum3_000749
Spectrum4_001751
Spectrum5_000602
Spectrum_001381
UNII-935E97BOY8
Usaf cb-13
Vitamin B11
Vitamin B9
Vitamin Bc
Vitamin Be
Vitamin M
bmse000299
folic acid
nchembio.108-comp10
5
Flavin MononucleotideexperimentalPhase 2, Phase 36146-17-8643976
Synonyms:
FMN
Flanin
Flavine mononucleotide
Flavol
Riboflavin
Riboflavin 5'-monophosphate
Riboflavin 5'-phosphate
Riboflavin Mononucleotide
Riboflavin monophosphate
 
Riboflavin phosphate
Riboflavin-5'-phosphate na
Riboflavin-5-phosphate
Riboflavine 5'-monophosphate
Riboflavine 5'-phosphate
Riboflavine dihydrogen phosphate
Riboflavine monophosphate
Riboflavine phosphate
Riboflavine-5'-phosphate
Vitamin B2 phosphate
6Pharmaceutical SolutionsPhase 2, Phase 37793
7Photosensitizing AgentsPhase 2, Phase 3476
8Sodium Channel BlockersPhase 2, Phase 31515
9VitaminsPhase 2, Phase 35095
10Vitamin B ComplexPhase 2, Phase 34229
11Trace ElementsPhase 2, Phase 35802
12AnestheticsPhase 2, Phase 39001
13Peripheral Nervous System AgentsPhase 2, Phase 322776
14Central Nervous System DepressantsPhase 2, Phase 312806
15MicronutrientsPhase 2, Phase 35802
16Anti-Arrhythmia AgentsPhase 2, Phase 32969
17Anesthetics, LocalPhase 2, Phase 33272
18Dermatologic AgentsPhase 2, Phase 35674
19DextransPhase 2, Phase 399
20Diuretics, Potassium SparingPhase 2, Phase 31827
21Ophthalmic SolutionsPhase 31092
22MitomycinsPhase 3233
23Vitamin B2NutraceuticalPhase 2, Phase 3165
24Vitamin B9NutraceuticalPhase 2, Phase 34279
25FolateNutraceuticalPhase 2, Phase 34279
26Tetrahydrozoline593

Interventional clinical trials:

(show all 12)
idNameStatusNCT IDPhase
1Corneal Cross Linking and Topography Guided Excimer Laser TreatmentUnknown statusNCT01682993Phase 3
2Treatment of Keratoconus Using Collagen Cross-LinkingUnknown statusNCT00841386Phase 2, Phase 3
3Evaluating the Safety and Efficacy of the KXL System for Corneal Collagen Cross-Linking in Eyes Having KeratoconusRecruitingNCT02638376Phase 3
4Evaluation of Topical Riboflavin Exposed to UVA Radiation and Implantation of Corneal RingCompletedNCT00832897
5Study of Clinical Performance of Corneal Topography Measurement Using an Optical BiometerCompletedNCT01861925
6Changes of Visual Function, Ocular Surface Structures and Physiology After Long-Termed Contact Lens WearRecruitingNCT02894489
7Higher Irradiance in Keratoconus EctasiaRecruitingNCT01789333
8Study to Evaluate the Safety and Efficacy of HI-BRITE Large Diameter Rigid Gas Permeable Contact LensRecruitingNCT02812316
9Scleral Versus Corneal RGP Contact Lenses in Irregular Cornea DisordersEnrolling by invitationNCT02444923
10Measurement Repeatability in Contemporary AberrometryNot yet recruitingNCT02687022
11Biomechanical Properties of Keratoconic EyesNot yet recruitingNCT02476149
12Progressive Keratoconus or Ectasia Treatment PlanTemporarily not availableNCT01384773

Search NIH Clinical Center for Irregular Astigmatism

Genetic Tests for Irregular Astigmatism

About this section

Anatomical Context for Irregular Astigmatism

About this section

MalaCards organs/tissues related to Irregular Astigmatism:

35
Eye, Endothelial

Animal Models for Irregular Astigmatism or affiliated genes

About this section

MGI Mouse Phenotypes related to Irregular Astigmatism:

40
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053918.3CHST6, LOXL3, NYX, VSX1

Publications for Irregular Astigmatism

About this section

Articles related to Irregular Astigmatism:

(show top 50)    (show all 78)
idTitleAuthorsYear
1
Irregular Astigmatism After Corneal Transplantation-Efficacy and Safety of Topography-Guided Treatment. (26509761)
2015
2
Safety and efficacy of femtosecond laser-assisted arcuate keratotomy to treat irregular astigmatism after penetrating keratoplasty. (26189378)
2015
3
Stromal surface topography-guided custom ablation as a repair tool for corneal irregular astigmatism. (25599543)
2015
4
Transepithelial phototherapeutic keratectomy protocol for treating irregular astigmatism based on population epithelial thickness measurements by artemis very high-frequency digital ultrasound. (24972404)
2014
5
Topography-guided photorefractive keratectomy for irregular astigmatism after small incision lenticule extraction. (24972410)
2014
6
Visual outcomes of topography-guided excimer laser surgery for treatment of patients with irregular astigmatism. (23435799)
2014
7
Wearing time as a measure of success of scleral lenses for patients with irregular astigmatism. (24145901)
2013
8
Topography-guided transepithelial photorefractive keratectomy for irregular astigmatism using a 213 nm solid-state laser. (23158680)
2013
9
Irregular astigmatism after femtosecond laser refractive lenticule extraction. (23688883)
2013
10
Intrastromal corneal ring segment implantation for irregular astigmatism after laser in situ keratomileusis. (22520312)
2012
11
Advanced topography-guided (OcuLink) treatment of irregular astigmatism after epikeratophakia in keratoconus with the WaveLight excimer laser. (22094961)
2012
12
Toric soft contact lens fit in a postoperative LASIK keratoectasia patient with high and irregular astigmatism. (22019833)
2011
13
Customized photorefractive keratectomy for the correction of regular and irregular astigmatism after penetrating keratoplasty. (21912229)
2011
14
Femtosecond-assisted astigmatic keratotomy for post-keratoplasty irregular astigmatism. (19101418)
2009
15
Severe hyperopic shift and irregular astigmatism after radial keratotomy. (19812501)
2009
16
Management of irregular astigmatism following rotationally disoriented free cap after LASIK. (18500089)
2008
17
Irregular astigmatism after cataract surgery resulting from inadequate clear corneal incision formation. (19034136)
2008
18
Longitudinal changes in corneal irregular astigmatism and visual acuity in eyes with keratoconus. (17660986)
2007
19
Topographic customized photorefractive keratectomy for regular and irregular astigmatism after penetrating keratoplasty using the LIGI CIPTA/LaserSight platform. (17912938)
2007
20
Topography-guided ablation for treatment of patients with irregular astigmatism. (17326350)
2007
21
Strategic planning in topography-guided ablation of irregular astigmatism after laser refractive surgery. (16128335)
2005
22
Corneal irregular astigmatism after hyperopic laser in situ keratomileusis. (16160493)
2005
23
Treatment of irregular astigmatism and keratoconus with the VISX C-CAP method. (12881653)
2003
24
Topography-guided laser in situ keratomileusis (TOPOLINK) to correct irregular astigmatism after previous refractive surgery. (14518740)
2003
25
Fourier analysis of induced irregular astigmatism. Photorefractive keratectomy versus laser in situ keratomileusis in a bilateral cohort of hyperopic patients. (14522289)
2003
26
Management of irregular astigmatism after laser in situ keratomileusis. (12881656)
2003
27
RGP lens treats irregular astigmatism from intracorneal glass. (12861118)
2003
28
Correction of irregular astigmatism. (11927414)
2002
29
Correction of irregular astigmatism with excimer laser assisted by sodium hyaluronate. (11425683)
2001
30
Corneal irregular astigmatism and contrast sensitivity after photorefractive keratectomy. (11733260)
2001
31
Photorefractive keratectomy with customized segmental ablation to correct irregular astigmatism after laser in situ keratomileusis. (11316028)
2001
32
Surgically induced topographical abnormalities after LASIK: management of central islands, corneal ectasia, decentration, and irregular astigmatism. (11507346)
2001
33
Soft contact lenses for irregular astigmatism after laser in situ keratomileusis. (11758989)
2001
34
Management of irregular astigmatism. (10977770)
2000
35
Selective zonal ablations with excimer laser for correction of irregular astigmatism induced by refractive surgery. (10768327)
2000
36
Early clinical experience using custom excimer laser ablations to treat irregular astigmatism. (11033389)
2000
37
Management of irregular astigmatism with rigid gas permeable contact lenses. (10656303)
2000
38
Confocal microscopy of a patient with irregular astigmatism after LASIK reoperations and relaxation incisions. (10746447)
2000
39
Quantitative analysis of regular and irregular astigmatism induced by pterygium. (10422852)
1999
40
Topographic assessment of irregular astigmatism after photorefractive keratectomy. (9719967)
1998
41
Treatment of irregular astigmatism. (9610446)
1998
42
Treatment of irregular astigmatism with a broad beam excimer laser. (9427200)
1997
43
Disciform keratitis causing severe irregular astigmatism. (8743008)
1996
44
Slipped flap, irregular astigmatism, and undercorrection after automated lamellar keratoplasty. (8871868)
1996
45
Measurement of irregular astigmatism using semimeridian data from videokeratographs. (8871860)
1996
46
Corneal topography and irregular astigmatism. (8587769)
1995
47
The use of the SoftPerm lens for the correction of irregular astigmatism. (1499124)
1992
48
Escalation of keratospeak: regular and irregular astigmatism. (2248932)
1990
49
The importance of corneal asphericity and irregular astigmatism in refractive surgery. (2248929)
1990
50
Alternatives to toric contact lens fitting--for regular and irregular astigmatism. (2695881)
1989

Variations for Irregular Astigmatism

About this section

Expression for genes affiliated with Irregular Astigmatism

About this section
Search GEO for disease gene expression data for Irregular Astigmatism.

Pathways for genes affiliated with Irregular Astigmatism

About this section

GO Terms for genes affiliated with Irregular Astigmatism

About this section

Cellular components related to Irregular Astigmatism according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1cytosolic small ribosomal subunitGO:00226279.5RPS27, RPS29

Biological processes related to Irregular Astigmatism according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1SRP-dependent cotranslational protein targeting to membraneGO:00066149.9RPS27, RPS29
2viral transcriptionGO:00190839.8RPS27, RPS29
3translational initiationGO:00064139.5RPS27, RPS29
4nuclear-transcribed mRNA catabolic process, nonsense-mediated decayGO:00001849.4RPS27, RPS29

Sources for Irregular Astigmatism

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
26GTR
27HGMD
28HMDB
29ICD10
30ICD10 via Orphanet
31ICD9CM
32IUPHAR
33KEGG
36MedGen
38MeSH
39MESH via Orphanet
40MGI
43NCI
44NCIt
45NDF-RT
48NINDS
49Novoseek
51OMIM
52OMIM via Orphanet
56PubMed
57QIAGEN
62SNOMED-CT via Orphanet
66Tumor Gene Family of Databases
67UMLS
68UMLS via Orphanet